Emily Rosenfeld, Other
Emily Rosenfeld, Other
Research Associate
California Pacific Medical Center Research Institute
45 Castro Street
San Francisco,
CA
USA
94114
Papers:
128
Disease stabilization vs. response after bevacizumab treatment in recurrent ovarian cancer: how do we determine clinical efficacy?